Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Analytical Biochemistry|December 1, 2007
Staurosporine-based binding assay for testing the affinity of compounds to protein kinasesGanesh H Iyer, Paul Taslimi, S PazhanisamyThe Biochemical Journal|August 5, 2004
New insights into the structure-function relationships of Rho-associated kinase: a thermodynamic and hydrodynamic study of the dimer-to-monomer transition and its kinetic implicationsJohn D Doran, Xun Liu, Paul Taslimi, et al.The Journal of Biological Chemistry|October 27, 2005
The structure of dimeric ROCK I reveals the mechanism for ligand selectivityMarc Jacobs, Koto Hayakawa, Lora Swenson, et al.Biochemical and Biophysical Research Communications|October 27, 2006
Resveratrol inhibits firefly luciferaseAdel Bakhtiarova, Paul Taslimi, Stephen J Elliman, et al.Bioorganic & Medicinal Chemistry Letters|April 14, 2009
Structure-based design and parallel synthesis of N-benzyl isatin oximes as JNK3 MAP kinase inhibitorsJingrong Cao, Huai Gao, Guy Bemis, et al.Journal of Medicinal Chemistry|June 4, 2015
Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) InhibitorsJeremy Green, Jingrong Cao, Upul K Bandarage, et al.Plos One|April 18, 2013
Protein complex interactor analysis and differential activity of KDM3 subfamily members towards H3K9 methylationMichael Brauchle, Zhiping Yao, Rishi Arora, et al.Bioorganic & Medicinal Chemistry Letters|October 22, 2008
Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK)Luc J Farmer, Guy Bemis, Shawn D Britt, et al.Journal of Medicinal Chemistry|August 4, 2017
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension ModelsKen Yamada, Julian Levell, Taeyong Yoon, et al.ACS Medicinal Chemistry Letters|June 6, 2014
The Discovery of VX-745: A Novel and Selective p38α Kinase InhibitorJohn P Duffy, Edmund M Harrington, Francesco G Salituro, et al.Pageof 1